BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7934913)

  • 1. Construction and pathogenicity of Aspergillus fumigatus mutants that do not produce the ribotoxin restrictocin.
    Smith JM; Davies JE; Holden DW
    Mol Microbiol; 1993 Sep; 9(5):1071-7. PubMed ID: 7934913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virulence of Aspergillus fumigatus double mutants lacking restriction and an alkaline protease in a low-dose model of invasive pulmonary aspergillosis.
    Smith JM; Tang CM; Van Noorden S; Holden DW
    Infect Immun; 1994 Dec; 62(12):5247-54. PubMed ID: 7960101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A transformant of Aspergillus fumigatus deficient in the antigenic cytotoxin ASPFI.
    Paris S; Monod M; Diaquin M; Lamy B; Arruda LK; Punt PJ; Latgé JP
    FEMS Microbiol Lett; 1993 Jul; 111(1):31-6. PubMed ID: 8359677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation and nucleotide sequence of the Aspergillus restrictus gene coding for the ribonucleolytic toxin restrictocin and its expression in Aspergillus nidulans: the leader sequence protects producing strains from suicide.
    Lamy B; Davies J
    Nucleic Acids Res; 1991 Mar; 19(5):1001-6. PubMed ID: 2020539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of alkaline protease or restrictocin deficient mutants of Aspergillus fumigatus on human polymorphonuclear leukocytes.
    Ikegami Y; Amitani R; Murayama T; Nawada R; Lee WJ; Kawanami R; Kuze F
    Eur Respir J; 1998 Sep; 12(3):607-11. PubMed ID: 9762788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterologous expression of the cytotoxin restriction in Aspergillus nidulans and Aspergillus niger.
    Brandhorst T; Yang R; Kenealy WR
    Protein Expr Purif; 1994 Oct; 5(5):486-97. PubMed ID: 7827506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction, expression and characterization of chimaeric toxins containing the ribonucleolytic toxin restrictocin: intracellular mechanism of action.
    Rathore D; Batra JK
    Biochem J; 1997 Jun; 324 ( Pt 3)(Pt 3):815-22. PubMed ID: 9210405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular genetics of Aspergillus pathogenicity.
    Holden DW; Tang CM; Smith JM
    Antonie Van Leeuwenhoek; 1994; 65(3):251-5. PubMed ID: 7847892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probing the active site of mitogillin, a fungal ribotoxin.
    Kao R; Shea JE; Davies J; Holden DW
    Mol Microbiol; 1998 Aug; 29(4):1019-27. PubMed ID: 9767570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of restrictocin production in Aspergillus restrictus.
    Yang R; Kenealy WR
    J Gen Microbiol; 1992 Jul; 138(7):1421-7. PubMed ID: 1512574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymerase chain reaction amplification of Asp f I and alkaline protease genes from fungus balls: clinical application in pulmonary aspergillosis.
    Urata T; Kobayashi M; Imamura J; Tanaka Y; Muneishi H; Iwahara Y; Uemura Y; Taguchi H; Miyoshi I
    Intern Med; 1997 Jan; 36(1):19-27. PubMed ID: 9058095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secretion of a potential virulence factor, a fungal ribonucleotoxin, during human aspergillosis infections.
    Lamy B; Moutaouakil M; Latge JP; Davies J
    Mol Microbiol; 1991 Jul; 5(7):1811-5. PubMed ID: 1943712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of specific target recognition and RNA hydrolysis by ribonucleolytic toxin restrictocin.
    Nayak SK; Bagga S; Gaur D; Nair DT; Salunke DM; Batra JK
    Biochemistry; 2001 Aug; 40(31):9115-24. PubMed ID: 11478878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of individual cysteine residues and disulfide bonds in the structure and function of Aspergillus ribonucleolytic toxin restrictocin.
    Nayak SK; Rathore D; Batra JK
    Biochemistry; 1999 Aug; 38(31):10052-8. PubMed ID: 10433712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genes and molecules involved in Aspergillus fumigatus virulence.
    Rementeria A; López-Molina N; Ludwig A; Vivanco AB; Bikandi J; Pontón J; Garaizar J
    Rev Iberoam Micol; 2005 Mar; 22(1):1-23. PubMed ID: 15813678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of the Aspergillus fumigatus areA gene in invasive pulmonary aspergillosis.
    Hensel M; Arst HN; Aufauvre-Brown A; Holden DW
    Mol Gen Genet; 1998 Jun; 258(5):553-7. PubMed ID: 9669338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytotoxic activity of ribonucleolytic toxin restrictocin-based chimeric toxins targeted to epidermal growth factor receptor.
    Rathore D; Batra JK
    FEBS Lett; 1997 May; 407(3):275-9. PubMed ID: 9175867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of ribonucleolytic toxin restrictocin in Escherichia coli: purification and characterization.
    Rathore D; Nayak SK; Batra JK
    FEBS Lett; 1996 Sep; 392(3):259-62. PubMed ID: 8774857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new experimental murine aspergillosis model to identify strains of Aspergillus fumigatus with reduced virulence.
    Sarfati J; Diaquin M; Debeaupuis JP; Schmidt A; Lecaque D; Beauvais A; Latge JP
    Nihon Ishinkin Gakkai Zasshi; 2002; 43(4):203-13. PubMed ID: 12402022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of virulence between clinical and environmental isolates of Aspergillus fumigatus.
    Aufauvre-Brown A; Brown JS; Holden DW
    Eur J Clin Microbiol Infect Dis; 1998 Nov; 17(11):778-80. PubMed ID: 9923518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.